The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

XERS FINANCIAL STATEMENTS

Xeris Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

XERSXeris Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue335.4 M $Gross Profit279.5 M $ · 83%Operating Income36.6 M $ · 11%Pre-tax Income-17.2 M $ · -5%Net Income to Owners-17.2 M $ · -5%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue335.4 M $+36.3%
Gross Profit279.5 M $+40.0%
Operating Income36.6 M $—
EBITDA16.4 M $+122.0%
Net Income to Owners-17.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets411.9 M
  • Current Liabilities189.6 M $45%
  • Long-term Liabilities232.1 M $55%

Key Figures

YoY change
Total Assets411.9 M $+23.1%
Total Liabilities421.6 M $+19.1%
Total Equity-9.7 M $—
Cash & ST Investments121.7 M $+105.4%
Total Debt289.4 M $+12.5%
Net Debt167.7 M $-15.3%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M-50 M050 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
020 M40 M60 M56.6 M $Operating-938 K $Investing6.7 M $Financing62.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow56.6 M $—
Capital Expenditures1.2 M $+105.3%
Free Cash Flow55.4 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on XERS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.